For: | Maeda H, Kobayashi M, Sakamoto J. Evaluation and treatment of malignant ascites secondary to gastric cancer. World J Gastroenterol 2015; 21(39): 10936-10947 [PMID: 26494952 DOI: 10.3748/wjg.v21.i39.10936] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v21/i39/10936.htm |
Number | Citing Articles |
1 |
Ben Davidson, Claire Michael, Pınar Fırat. Serous Effusions. 2018; : 119 doi: 10.1007/978-3-319-76478-8_7
|
2 |
R. Sendhil, A. Arulmurugan, G. Jose Moses, R. Kaviarasan, P. Ramadoss. Earlier detection of occult peritoneal metastasis by Pro_Segment in gastric cancer employing augmented deep learning techniques in big data with medical IoT (MIoT). Journal of Intelligent & Fuzzy Systems 2023; : 1 doi: 10.3233/JIFS-233510
|
3 |
Sujin Hyung, Jihoon Ko, You Jeong Heo, Steven M. Blum, Seung Tae Kim, Se Hoon Park, Joon Oh Park, Won Ki Kang, Ho Yeong Lim, Samuel J. Klempner, Jeeyun Lee. Patient-derived exosomes facilitate therapeutic targeting of oncogenic MET in advanced gastric cancer. Science Advances 2023; 9(47) doi: 10.1126/sciadv.adk1098
|
4 |
Daniel Pinto, Fernando Schmitt. Current applications of molecular testing on body cavity fluids. Diagnostic Cytopathology 2020; 48(9): 840 doi: 10.1002/dc.24410
|
5 |
|
6 |
Mauricio Antonio Castaño Cárcamo, Angélica Viviana Fletcher Prieto. Terapia intraperitoneal paliativa en ascitis maligna refractaria. Revista Colombiana de Cancerología 2018; 22(1): 18 doi: 10.1016/j.rccan.2017.01.001
|
7 |
Jie Li, Huawei Xu, Lixing Zhang, Lele Song, Dan Feng, Xiaobo Peng, Meihong Wu, Yang Zou, Bin Wang, Lixing Zhan, Guoqiang Hua, Xianbao Zhan. Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening. Journal of Cancer Research and Clinical Oncology 2019; 145(11): 2637 doi: 10.1007/s00432-019-03004-z
|
8 |
Lorenzo Nicolè, Filippo Cappello, Rocco Cappellesso, Christopher J. VandenBussche, Ambrogio Fassina. MicroRNA profiling in serous cavity specimens: Diagnostic challenges and new opportunities. Cancer Cytopathology 2019; 127(8): 493 doi: 10.1002/cncy.22143
|
9 |
Momin T. Siddiqui, Fernando Schmitt, Andrew Churg. Proceedings of the American Society of Cytopathology companion session at the 2019 United States and Canadian Academy of Pathology Annual meeting, part 2: effusion cytology with focus on theranostics and diagnosis of malignant mesothelioma. Journal of the American Society of Cytopathology 2019; 8(6): 352 doi: 10.1016/j.jasc.2019.07.005
|
10 |
Qiuping Xu, Jie Shao, Shu Su, Jia Wei, Fangjun Chen, Fanyan Meng, Yang Zhao, Juan Du, Zhengyun Zou, Xiaoping Qian, Baorui Liu. Activation and propagation of tumor-infiltrating lymphocytes from malignant pleural effusion and ascites with engineered cells for costimulatory enhancement. Cellular Immunology 2018; 331: 1 doi: 10.1016/j.cellimm.2018.04.006
|
11 |
Ran Wang, Xingshun Qi, Xiaozhong Guo. Quantification of ascites based on abdomino‑pelvic computed tomography scans for predicting the in‑hospital mortality of liver cirrhosis. Experimental and Therapeutic Medicine 2017; doi: 10.3892/etm.2017.5321
|
12 |
Lin Cui, Xiuqing Wang, Dekai Zhang. TLRs as a Promise Target Along With Immune Checkpoint Against Gastric Cancer. Frontiers in Cell and Developmental Biology 2021; 8 doi: 10.3389/fcell.2020.611444
|
13 |
Nicolae Bacalbasa, Camelia Diaconu, Bogdan Socea, Florentina Gherghiceanu, Cornel Savu, Mihai Dimitriu, Irina Balescu, Ioan Cordos. Neoadjuvant intraperitoneal chemotherapy for advanced stage gastric cancer (Review). Experimental and Therapeutic Medicine 2021; 22(5) doi: 10.3892/etm.2021.10749
|
14 |
Mona Passler, Maximilian Krafft, Eliane Tabea Taube, Jalid Sehouli, Klaus Pietzner. Aktuelle Therapiestrategien bei malignem Aszites. Im Focus Onkologie 2017; 20(12): 32 doi: 10.1007/s15015-017-3667-2
|
15 |
Caitlin Hodge, Brian D. Badgwell. Palliation of malignant ascites. Journal of Surgical Oncology 2019; 120(1): 67 doi: 10.1002/jso.25453
|
16 |
Mohamed Abdallah Salman, Ahmed Abdallah Salman, Ahmed Hamdy, Rasha M. Abdel Samie, Mohammed Ewid, Tarek Elsayed Abouregal, Sayed M. Seif El Nasr, Hesham Elkassar, Ahmed Abdallah, Mohamed Yousef, Amro Abdelaziz Mohammed Ismail, Ayman Alsebaey, Mohamed Matter. Predictive value of omental thickness on ultrasonography for diagnosis of unexplained ascites, an Egyptian centre study. Asian Journal of Surgery 2020; 43(1): 13 doi: 10.1016/j.asjsur.2019.03.004
|
17 |
Yuan Jiao, Xiaobo Peng, Yujie Wang, Zhibin Hao, Ling Chen, Meihong Wu, Yingyi Zhang, Jie Li, Wenlin Li, Xianbao Zhan. Malignant ascites supernatant enhances the proliferation of gastric cancer cells partially via the upregulation of asparagine synthetase. Oncology Letters 2023; 26(4) doi: 10.3892/ol.2023.14005
|
18 |
Junzi Zhang, Zhaoxue Qi, Wenjie Ou, Xuguang Mi, Yanqiu Fang, Wenqi Zhang, Zhen Yang, Ying Zhou, Xiuying Lin, Junjie Hou, Zhixin Yuan. Advances in the treatment of malignant ascites in China. Supportive Care in Cancer 2024; 32(2) doi: 10.1007/s00520-023-08299-w
|
19 |
Feng Su, Yu Sun, Yajie Hu, Peijiang Yuan, Xinyu Wang, Qian Wang, Jianmin Li, Jia-Fu Ji. Development and validation of a deep learning system for ascites cytopathology interpretation. Gastric Cancer 2020; 23(6): 1041 doi: 10.1007/s10120-020-01093-1
|
20 |
Trudy Hong. Diagnostic challenges in gastric adenocarcinoma: a case report. MOJ Clinical & Medical Case Reports 2021; 11(4): 96 doi: 10.15406/mojcr.2021.11.00390
|
21 |
Shumei Song, Yan Xu, Longfei Huo, Shuangtao Zhao, Ruiping Wang, Yuan Li, Ailing W. Scott, Melissa Pool Pizzi, Ying Wang, Yibo Fan, Kazuto Harada, Jiankang Jin, Lang Ma, Xiaodan Yao, Namita D. Shanbhag, Qiong Gan, Sinchita Roy-Chowdhuri, Brian D. Badgwell, Zhenning Wang, Linghua Wang, Jaffer A. Ajani. Patient-derived cell lines and orthotopic mouse model of peritoneal carcinomatosis recapitulate molecular and phenotypic features of human gastric adenocarcinoma. Journal of Experimental & Clinical Cancer Research 2021; 40(1) doi: 10.1186/s13046-021-02003-8
|
22 |
Daryl K. A. Chia, Raghav Sundar, Guowei Kim, Jia Jun Ang, Jeffrey H. Y. Lum, Min En Nga, Giap Hean Goh, Ju Ee Seet, Cheng Ean Chee, Hon Lyn Tan, Jingshan Ho, Natalie Y. L. Ngoi, Matilda X. W. Lee, Vaishnavi Muthu, Gloria H. J. Chan, Angela S. L. Pang, Yvonne L. E. Ang, Joan R. E. Choo, Joline S. J. Lim, Jun Liang Teh, Aung Lwin, Yuen Soon, Asim Shabbir, Jimmy B. Y. So, Wei Peng Yong. Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases. Annals of Surgical Oncology 2022; 29(13): 8597 doi: 10.1245/s10434-022-11998-z
|
23 |
英健 王. Effects of TGF-β and IL-6 on the Development and Metastasis of Gastric Cancer. Medical Diagnosis 2022; 12(01): 65 doi: 10.12677/MD.2022.121011
|
24 |
Lisa M. Rooper, Syed Z. Ali, Matthew T. Olson. A specimen volume of ≥80 mL improves cytologic sensitivity for malignant ascites: a retrospective analysis of 2665 cases. Journal of the American Society of Cytopathology 2016; 5(5): 301 doi: 10.1016/j.jasc.2016.04.004
|
25 |
Yehong Bin, Dong Lan, Wenguang Bao, Haiyan Yang, Shengsheng Zhou, Fengxiang Huang, Man Wang, Zhigang Peng. SOX combined with intraperitoneal perfusion of docetaxel compared with DOS regimen in the first-line therapy for advanced gastric cancer with malignant ascites: a prospective observation. Trials 2022; 23(1) doi: 10.1186/s13063-022-06143-w
|
26 |
Pratyaksha Rana, Pankaj Gupta. Tuberculosis of the Gastrointestinal system. 2022; : 191 doi: 10.1007/978-981-16-9053-2_12
|
27 |
J.M. Berger, A. Alany, R. Puhr, L. Berchtold, A. Friedrich, B. Scheiner, G.W. Prager, A.S. Berghoff, M. Preusser, E.S. Bergen. Clinical risk factors for ascites in metastatic pancreatic cancer. ESMO Open 2023; 8(2): 101200 doi: 10.1016/j.esmoop.2023.101200
|
28 |
Katrina McGinty. Acute Abdomen in the Oncology Patient. Seminars in Roentgenology 2020; 55(4): 400 doi: 10.1053/j.ro.2020.07.001
|
29 |
Amir Parray, Vikas Gupta, Vikram A. Chaudhari, Shailesh V. Shrikhande, Manish S. Bhandare. Role of intraperitoneal chemotherapy in gastric cancer. Surgery in Practice and Science 2021; 4: 100025 doi: 10.1016/j.sipas.2020.100025
|
30 |
Jieun Yun, Sang-Bae Han, Hong Jun Kim, Se-il Go, Won Sup Lee, Woo Kyun Bae, Sang-Hee Cho, Eun-Kee Song, Ok-Jun Lee, Hee Kyung Kim, Yaewon Yang, Jihyun Kwon, Hee Bok Chae, Ki Hyeong Lee, Hye Sook Han. Exosomal miR-181b-5p Downregulation in Ascites Serves as a Potential Diagnostic Biomarker for Gastric Cancer-associated Malignant Ascites. Journal of Gastric Cancer 2019; 19(3): 301 doi: 10.5230/jgc.2019.19.e27
|
31 |
Cristina Prata Amendola, Luís Gustavo Capochin Romagnolo, Raphael L. C. Araujo. Oncologic Critical Care. 2019; : 1 doi: 10.1007/978-3-319-74698-2_73-1
|
32 |
Hiromichi Maeda, Maho Sato, Michiya Kobayashi, Nobuhiro Takiguchi, Takaki Yoshikawa, Shigefumi Yoshino, Kazuhiro Yoshida, Akira Tsuburaya, Junichi Sakamoto, Satoshi Morita. Validity of the Japanese version of functional assessment of cancer therapy-gastric (FACT-Ga) and its sensitivity to ascites volume change: a retrospective analysis of Japanese clinical trial participants. Supportive Care in Cancer 2016; 24(11): 4515 doi: 10.1007/s00520-016-3290-3
|
33 |
Jie Jiao, Chengzhen Li, Guanying Yu, Lei Zhang, Xiaoyan Shi, Jingdu Yan, Houjun Zhang, Peiming Guo. Efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in the management of malignant ascites. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01956-y
|
34 |
Leidy Barrera, Diego Gonzalez, Luisa Pelaez. Chylous Ascites Related to Radiotherapy in a Patient With Gastric Cancer. Cureus 2023; doi: 10.7759/cureus.38716
|
35 |
Yalei Zhang, Ling Qian, Kun Chen, Sijia Gu, Jia Wang, Zhiqiang Meng, Ye Li, Peng Wang. Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response. Molecular Therapy - Oncolytics 2022; 25: 31 doi: 10.1016/j.omto.2022.03.003
|
36 |
Huimin Lin, Guoyuan Yang, Bei Ding, Miao Zhang, Mingjun Zhang, Fuhua Yan, Ying Qu, Huan Zhang. Secreted frizzled-related protein 1 overexpression in gastric cancer: Relationship with radiological findings of dual-energy spectral CT and PET-CT. Scientific Reports 2017; 7(1) doi: 10.1038/srep42020
|
37 |
Chao-Cheng Chen, Jia-Je Li, Nai-Hua Guo, Deng-Yuan Chang, Chung-Yih Wang, Jenn-Tzong Chen, Wuu-Jyh Lin, Kwan-Hwa Chi, Yi-Jang Lee, Ren-Shyan Liu, Chuan-Lin Chen, Hsin-Ell Wang. Evaluation of the Biological Behavior of a Gold Nanocore-Encapsulated Human Serum Albumin Nanoparticle (Au@HSANP) in a CT-26 Tumor/Ascites Mouse Model after Intravenous/Intraperitoneal Administration. International Journal of Molecular Sciences 2019; 20(1): 217 doi: 10.3390/ijms20010217
|
38 |
V. A. Markovich, S. A. Tuzikov, E. O. Rodionov, N. O. Popova, M. M. Tsyganov, S. V. Miller, D. V. Podolko, I. A. Tsydenova, M. K. Ibragimova, N. V. Litviakov. Combined modality treatment of patients with stage IV gastric cancer with peritoneal carcinomatosis. Siberian journal of oncology 2023; 22(1): 24 doi: 10.21294/1814-4861-2023-22-1-24-34
|
39 |
Ange Zhang, Xiaoming Zou, Shifeng Yang, Hao Yang, Zhen Ma, Jiacheng Li. Effect of NETs/COX-2 pathway on immune microenvironment and metastasis in gastric cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1177604
|
40 |
Lingyun Zhang, Jiayu Zhang, Yan Wang, Wei Li, Shan Yu, Qian Li, Yiyi Yu, Tianshu Liu, Yuehong Cui. Efficacy of AS versus SOX regimen as first-line chemotherapy for gastric cancer patients with peritoneal metastasis: a real-world study. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02369-9
|
41 |
Chengmao Zhou, Ying Wang, Mu-Huo Ji, Jianhua Tong, Jian-Jun Yang, Hongping Xia. Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning. Cancer Control 2020; 27(1) doi: 10.1177/1073274820968900
|
42 |
Cristina Prata Amendola, Luís Gustavo Capochin Romagnolo, Raphael L. C. Araujo. Oncologic Critical Care. 2020; : 885 doi: 10.1007/978-3-319-74588-6_73
|
43 |
Yasuo Hamamoto, Yongzhe Piao, Akitaka Makiyama. Achieving sequential therapy in advanced gastric cancer: the importance of appropriate patient management for the elderly and/or those with ascites. Gastric Cancer 2020; 23(3): 363 doi: 10.1007/s10120-020-01067-3
|
44 |
Ju-Hee Lee, Sung-Joon Kwon, Mimi Kim, Bo-Kyeong Kang. Prevalence and Clinical Implications of Ascites in Gastric Cancer Patients after Curative Surgery. Journal of Clinical Medicine 2021; 10(16): 3557 doi: 10.3390/jcm10163557
|
45 |
Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, Anthony K. Park, Sang-In Kim, Jianming Lu, Hannah Valencia, Yuman Fong, Yanghee Woo. Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer Patients. International Journal of Molecular Sciences 2023; 24(18): 14189 doi: 10.3390/ijms241814189
|
46 |
Marta Tkacz, Maciej Tarnowski, Agata Poniewierska-Baran, Karol Serwin, Anna Madej-Michniewicz, Anna Deskur, Bogusław Czerny, Teresa Starzyńska. Impact of Selected Serum Factors on Metastatic Potential of Gastric Cancer Cells. Diagnostics 2022; 12(3): 700 doi: 10.3390/diagnostics12030700
|
47 |
Adriana C. Gamboa, Joshua H. Winer. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer. Cancers 2019; 11(11): 1662 doi: 10.3390/cancers11111662
|
48 |
Hong-Wei Zhang, Jian-Jun Yang, Ji-Yang Zheng, Li Sun, Xue-Wen Yang, Guo-Cai Li. Postoperative intraperitoneal hyperthermic perfusion improve survival for advanced gastric cancer. Medicine 2019; 98(30): e16598 doi: 10.1097/MD.0000000000016598
|
49 |
Luai Al-Marzouki, Vivian S. Stavrakos, Sanjima Pal, Betty Giannias, France Bourdeau, Roni Rayes, Nicholas Bertos, Sara Najmeh, Jonathan D. Spicer, Jonathan Cools-Lartigue, Swneke D. Bailey, Lorenzo Ferri, Veena Sangwan. Soluble factors in malignant ascites promote the metastatic adhesion of gastric adenocarcinoma cells. Gastric Cancer 2023; 26(1): 55 doi: 10.1007/s10120-022-01338-1
|
50 |
Akira Ueda, Satoshi Yuki, Takayuki Ando, Ayumu Hosokawa, Naokatsu Nakada, Yosuke Kito, Iori Motoo, Ken Ito, Miho Sakumura, Yurika Nakayama, Yuko Ueda, Shinya Kajiura, Koji Nakashima, Kazuaki Harada, Yasuyuki Kawamoto, Yoshito Komatsu, Ichiro Yasuda. CA125 Kinetics as a Potential Biomarker for Peritoneal Metastasis Progression following Taxane-Plus-Ramucirumab Administration in Patients with Advanced Gastric Cancer. Cancers 2024; 16(5): 871 doi: 10.3390/cancers16050871
|
51 |
Zhouwei Zhan, Xiaojie Wang, Jiami Yu, Jingxian Zheng, Yi Zeng, Mingyao Sun, Li Peng, Zengqing Guo, Bijuan Chen. Intraperitoneal Infusion of Recombinant Human Endostatin Improves Prognosis in Gastric Cancer Ascites. Future Oncology 2022; 18(10): 1259 doi: 10.2217/fon-2021-0896
|
52 |
Zhixian Lin, Jiangfeng Chen, Yunxia Liu. The efficacy of traditional chinese medicine combined with hyperthermic intraperitoneal chemotherapy for malignant ascites: A systematic review and meta-analysis. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.938472
|
53 |
Furong Kou, Jifang Gong, Yan Li, Jian Li, Xiaotian Zhang, Jie Li, Lin Shen. Phase I study of intraperitoneal bevacizumab for treating refractory malignant ascites. Journal of International Medical Research 2021; 49(2) doi: 10.1177/0300060520986664
|
54 |
Yan Yang, Shujuan Guan, Zihao Ou, Weiqi Li, Lizhi Yan, Bo Situ. Advances in AI‐based cancer cytopathology. Interdisciplinary Medicine 2023; 1(3) doi: 10.1002/INMD.20230013
|
55 |
Ling-Nan Zheng, Feng Wen, Ping Xu, Shuang Zhang. Prognostic significance of malignant ascites in gastric cancer patients with peritoneal metastasis: A systemic review and meta-analysis. World Journal of Clinical Cases 2019; 7(20): 3247-3258 doi: 10.12998/wjcc.v7.i20.3247
|
56 |
Caitlin Hodge, Brian Badgwell. Oncologic Emergency Medicine. 2021; : 797 doi: 10.1007/978-3-030-67123-5_59
|
57 |
V. A. Markovich, S. A. Tuzikov, E. O. Rodionov, N. V. Litvyakov, N. O. Popova, M. M. Tsyganov, L. V. Levonyan, S. V. Miller, D. V. Podolko, I. A. Tsydenova, M. K. Ibragimova. Gastric cancer: modern approaches and prospects of treatment for peritoneal carcinomatosis (literature review). Siberian journal of oncology 2022; 20(6): 104 doi: 10.21294/1814-4861-2021-20-6-104-113
|